In this lecture Dr. Mobeen discusses the severeity assessment of asthma, management approach according to the severeity, and drugs with their dose adjustment in a 6 step approach.
Initial visit workup:
- Diagnosis (separate lecture)
- Severity assessment
- Medication.
- Inhaled Corticosteroids (ICS)
- Short acting beta agonists (SABA)
- Long acting beta agonists (LABA)
- Leukotrine Receptor Antagonists (LTRA)
- Cromolyn
- Theophyline
- Oral Corticosteroids
- Plan of treatment.
- Follow up
Follow up visit:
- Assess control
- Review medication compliance
- Review side-effects
- Decide medication modification if needed.
- Update the plan if necessary.
- Plan follow up.
In this video we will learn about:
1. Step wise approach to asthma management.
2. Severity assessment.
3. SABA and mechanism of action.
4. Oral and inhaled corticosteroids.
5. Leukotriene receptor antagonist.
6. Plan of treatment.
7. Assessment of compliance and improvement.
8. Side effects of treatment.
Faculty
In addition to the presenter, following authors may have helped with the content writing, review,
or approval:
CME, CE, CEU and Other Credit Types:
ACCME Accreditation Statement
The DrBeen Corp is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to
provide continuing medical education for physicians.
AMA Credit Designation Statement
The DrBeen Corp designates this enduring material for a maximum of 0.75 AMA PRA Category 1
Credits™.
Physicians should claim only the credit commensurate with the extent of their participation in the
activity.
Disclosure Information
In accordance with the disclosure policies of DrBeen Corp and the ACCME (Accreditation Council for
Continuing Medical Education), we are committed to upholding principles of balance, independence,
objectivity, and scientific rigor in all of our Continuing Medical Education (CME) and Continuing
Education (CE) activities. These policies include the careful management and mitigation of any relevant
financial relationships with organizations that are not eligible.
All members of the Activity Planning Committee and presenters have disclosed their relevant financial
relationships. The DrBeen Corp CE Committee has thoroughly reviewed these disclosures and determined
that these relationships are not deemed inappropriate in the context of their respective presentations.
Additionally, they are found to be consistent with the educational objectives and the integrity of the
activity.
| Faculty |
Disclosures |
| Dr. Mobeen Syed |
Author declares no conflict of interest. |
Write A New Comment
0 Comments